Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Barbara Fazeny"'
Autor:
Marco Hassler, Barbara Fazeny-Doerner, Johannes A. Hainfellner, Christine Marosi, Sonja Seidl, Daniela Prayer, Matthias Preusser, Karl Rössler
Publikováno v:
Cancer Genetics and Cytogenetics. 166:46-55
We present a small series of patients with primary glioblastoma multiforme (GBM), and combine individual genetic data with pathohistologic characteristics and clinical outcome. Eighteen patients (12 men, 6 women, median age 51 years) with histologica
Publikováno v:
American Journal of Preventive Medicine. 28:65-69
Background To assess the prevalence of food/foreign body asphyxia in the elderly Viennese population in order to reduce the incidence of these fatal events. Methods This is an autopsy-based, retrospective study in Vienna, Austria. Participants includ
Autor:
Barbara Fazeny-Dörner, Ichi Okamoto, Catharina Wenzel, Christine Marosi, Martin Filipits, Negar Fakhrai, Margarethe Rudas, Maria Piribauer, Christine Pirker, Walter Berger, Roland Sedivy
Publikováno v:
Cancer Genetics and Cytogenetics. 146:161-166
To assess a potential common pattern of genetic alterations in chemotherapy-resistant tumors we analyzed four tumors from breast cancer patients (patients 1-4) after neoadjuvant chemotherapy, by comparative genome hybridization (CGH) and conventional
Autor:
Karin Dieckmann, Karl Ungersböck, Barbara Fazeny-Dörner, Christine Marosi, Maria Piribauer, Karl Rössler, Mario Veitl, Catharina Wenzel
Publikováno v:
Anti-Cancer Drugs. 14:305-312
The aim of this study was to assess survival and prognostic factors of 98 consecutive patients with unresectable glioblastoma multiforme (GBM) after stereotactic biopsy. Patients were diagnosed between 1993 and 1998, and the treatment modality subseq
Autor:
Ernst Sim, Missliwetz J, Manfred Muhm, Peter Fasching, Barbara Fazeny-Dörner, Andrea Berzlanovich, Thomas Waldhoer, Christine Marosi
Publikováno v:
The American Journal of Medicine. 114:365-369
Purpose The aim of this study was to determine the causes of death in the very elderly. Methods We reviewed 24,081 consecutive autopsies performed over 10 years (1989 to 1998) at the Institute of Forensic Medicine, Vienna, Austria. We focused on auto
Autor:
Johannes A. Hainfellner, Peter Birner, Maria Piribauer, Monika Killer, Daniela Prayer, Karl Rössler, Karl Ungersböck, Barbara Fazeny-Dörner, Karin Dieckmann, Christine Marosi, Manfred Muhm, Thomas Czech
Publikováno v:
Anti-Cancer Drugs. 14:137-143
In our institution, 103 glioblastoma multiforme (GBM) patients aged from 55 to 83 years were treated since November 1994 as follows. All patients underwent surgical intervention (gross total resection, n = 35; subtotal resection, n = 38; stereotactic
Autor:
C. Marosi, Karl Rössler, Mario Veitl, Karl Ungersböck, Maria Piribauer, Barbara Fazeny-Dörner, Karin Dieckmann, Catharina Wenzel, Johannes A. Hainfellner
Publikováno v:
British Journal of Cancer
A total of 55 patients with histologically proven glioblastoma multiforme (total gross resection: n=24, subtotal resection: n=20, stereotactic biopsy: n=11) were treated with the combination of dacarbazine (D) (200 mg m(-2)) and fotemustine (F) (100
Autor:
Negar Fakhrai, Christine Marosi, Karl Ungersboeck, Alexander Becherer, Karin Dieckmann, Manuela Schmidinger, Monika Killer, Barbara Fazeny-Doerner, Daniela Prayer, Leo Linzmayer
Publikováno v:
Journal of Neuro-Oncology. 63:55-61
Background: Multimodal treatment of patients with glioblastoma multiforme (GBM) allows an increasing number of patients to survive beyond one year. On account of various neurological and psychophysiological impairments, however, these patients may no
Autor:
Manfred Muhm, Catharina Wenzel, Harald Vogelsang, Christoph C. Zielinski, T. Brodowicz, Christine Marosi, Mario Veitl, Barbara Fazeny-Dörner
Publikováno v:
Cancer Chemotherapy and Pharmacology. 49:294-298
Purpose: The aim of this study was to investigate the severity and time-course of alterations in gastroduodenal and intestinal permeability in relation to nausea/emesis following administration of the highly emetogenic polydrug regimen IFADIC (ifosfa
Autor:
Ernst Späth-Schwalbe, I. Genvresse, Georgios Plataniotis, Ulrich Wedding, J.H. Hartlapp, S. Linden-Lammering, C. Sachsenmaier, Martin C. Müller, G. Lammering, F. Fiedler, B. Straub, Anke Morgner, I.T.M. Boll, M.A. Theofanopoulou, A. Trojan, Günter Emons, Kurt Miller, T. Stallmach, S. Kollias, Mathias Hänel, G. Ehninger, M. Nicklisch, A. Chrissafidou, M. Teich, J. Mezger, Mark Schrader, T. Krauss, M. Malek, C. Marosi, Stephan Schmitz, Maria Piribauer, Regina Herbst, K. Friedrichsen, Volker Viereck, A. Huschmand Nia, S. Neser, B.C. Pestalozzi, Barbara Fazeny-Dörner, E. Musch, Ruediger Hehlmann, H.T. Steinmetz, G. Kolb, R. Heicappell, Carsten Bokemeyer, A. Hänel
Publikováno v:
Oncology Research and Treatment. 24:317-322